Business Context and Reporting Period
This Form 8-K Current Report was filed by Aemetis, Inc. on October 15, 2025, regarding events occurring on that date and effective as of August 31, 2025. The filing concerns Aemetis Biogas LLC ("ABGL"), a subsidiary of Aemetis, Inc., and its financial relationship with Protair-X Technologies Inc. ("Holder") and Third Eye Capital Corporation.
Key Financial Metrics and Agreements
The filing details a material definitive agreement regarding the redemption of Series A Preferred Units held by the Holder. Key financial terms include:
- Aggregate Redemption Price: Modified to $118.8 million, inclusive of a $2 million fee increase associated with the amendment.
- Redemption Deadline: Extended from August 31, 2025, to December 31, 2025.
- Contingent Credit Facility: If redemption does not occur by the deadline, a credit agreement will be triggered with the following terms:
- Effective Date: January 1, 2026.
- Maturity Date: September 1, 2026.
- Interest Rate: The greater of 16.0% or the prime rate plus 10.0%.
- Security: Guaranteed by Aemetis, Inc. and subsidiaries; secured by assets of ABGL and Guarantors.
The filing text does not provide specific values for revenue, operating profit, cash flow, or general liquidity metrics for the reporting period.
Material Changes
The primary material change is the extension of the redemption obligation for the Series A Preferred Units and the increase in the total redemption price. Additionally, the agreement establishes a conditional path to a high-interest credit facility if the redemption is not executed by the new deadline.
Outlook, Risks, and Contingencies
Contingencies: The filing outlines a significant contingency: failure to redeem the Preferred Units by December 31, 2025, will automatically result in the entry into a credit agreement with an interest rate potentially exceeding 16.0%.
Risks: The company faces a substantial liquidity requirement to meet the $118.8 million redemption price by year-end. Failure to do so exposes the company to high-cost debt and the encumbrance of assets via security interests.
Management Commentary: The filing contains no forward-looking guidance or management commentary beyond the terms of the agreement.
Investor Verification Checklist
- Verify Aemetis, Inc.'s current cash position and access to capital to determine the feasibility of the $118.8 million redemption by December 31, 2025.
- Assess the impact of a potential 16.0%+ interest rate debt obligation on future earnings if the redemption is not met.
- Review the full text of the Tenth Waiver and Amendment (Exhibit 10.1) for additional covenants or conditions not summarized in the 8-K.
- Confirm the status of the "Guarantors" and the specific assets pledged as security under the contingent Credit Agreement.